Receive our newsletter - data, analysis and deep insights on FDI delivered to you
Central America and the Caribbean / Dominican Republic

Oscor to invest $10m in its Dominican Republic manufacturing facilities

US-based medical device company Oscor will add 18,500m2 of clean room manufacturing space in the Dominican Republic and create more than 400 jobs by 2025.

Florida-based Oscor, a manufacturer of highly specialised diagnostic devices, has announced plans to expand its manufacturing facilities in Las Americas Industrial Free Zone Park, Dominican Republic. The company will invest $10m to add 18,500m2 of clean room manufacturing space in two phases by 2025.

The investment will ensure Oscor has leading-edge capabilities in cleanroom assembly, injection moulding, extrusion, laser processing, clean room packaging and sterilisation to support its OEM and contract manufacturing services. The company will also add more than 400 manufacturing employees and is expected to employ over 1,500 people in an area of more than  27,800m2 by 2024.

The new plant will produce implantable pacing and neuromodulation leads, next-generation introducer and guiding sheaths, and high-performance medical components as well as providing contract manufacturing, packaging and sterilisation services for other medical device companies.

Oscor currently operates two US manufacturing plants in Tampa Bay, Florida, two in the Dominican Republic, and sales and distribution offices in Palm Harbor, Florida, and Dusseldorf, Germany.

White papers from our partners

Naomi Davies

Naomi Davies

FDI consultant

Naomi Davies is an FDI consultant at Investment Monitor, with expertise in location benchmarking and cross-border investment.